Figure 2.
Figure 2. Cumulative incidence of aGVHD grades 2 to 4 and 3 to 4 for placebo and palifermin therapy.

Cumulative incidence of aGVHD grades 2 to 4 and 3 to 4 for placebo and palifermin therapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal